Navigation Links
BMP Sunstone Reports Second Quarter 2008 Financial Results
Date:8/11/2008

ating Expenses 14,957 2,629 24,074 5,102

Profit (Loss) From Operations 1,604 (1,653) 208 (3,472)

Other Income (Expense):

Interest Income 14 119 62 270

Interest (Expense) (1,611) (24) (3,180) (44)

Debt Issuance Cost Amortization (210) -- (420) --

Equity Method Investment Gain -- -- 996 --

Total Other Income (Expense) (1,807) 95 (2,542) 226

Loss Before Provision For Income

Taxes (203) (1,558) (2,334) (3,246)

Provision For Income Taxes 1,064 -- 1,411 --

Net Loss $(1,267) $(1,558) $(3,745) $(3,246)

Basic and Fully-Diluted Loss Per

Share $(0.03) $(0.06) $(0.10) $(0.12)

Basic and Fully-Diluted Weighted-

average Shares Outstanding 39,511 26,739 37,304 26,664

BMP Sunstone Corporation and Subsidiaries

Condensed Consolidated Balance Sheets

($ amounts in thousands)

(Unaudited)

June 30, December 31,

2008 2007

Assets

Current Assets:

Cash and Cash Equivalents $4,702 $22,837

Restricted Cash 1,297 1,297

Notes Receivable 17,547 --

Accounts Receivable, net of allowance

for doubtful accounts of $51 and $44 29,228 11,707

Inventory, net of allowance for

obsolescence of $0 9,501 2,897

Due f
'/>"/>

SOURCE BMP Sunstone Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. BMP Sunstone Corporation Appoints Zhiqiang Han to President and Chief Operating Officer
2. BMP Sunstone Receives Import Drug License (IDL) from SFDA
3. BMP Sunstone Receives SFDA Acceptance for Enablex(R) Clinical Trial
4. MGT Capital Investments Reports Second Quarter 2008 Financial Results and Provides Update on Recent Developments
5. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
6. Pharmos Corporation Reports 2008 Second Quarter Results
7. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
8. Par Pharmaceutical Reports Second Quarter 2008 Results
9. AutoImmune Inc. Reports 2008 Second Quarter Financial Results
10. SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results
11. Isis Reports Financial Results and Highlights for Second Quarter of 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013   Oligomerix, Inc. , ... disease modifying therapeutics for Alzheimer,s disease (AD) and ... its Series B financing, which includes both issuance ... would represent approximately $2.8M in new investments in ... supported the raise. Funding from ...
(Date:5/22/2013)... May 22, 2013  Cleveland BioLabs, Inc. (NASDAQ: CBLI) today ... Second Annual Marcum LLP Microcap Conference, May 30, in ... Neil Lyons , CPA, Chief Financial Officer of ... on May 30 at 1:30 p.m. Eastern Time.  A live ... on the Investors page of the Cleveland BioLabs website at ...
(Date:5/22/2013)... Envera announced today that Michael McErlean has ... has an extensive background in cell production and served ... , Mike Matheny, President and Owner of ... join our team”. “Mike’s background is perfectly suited to ... and downstream processing equipment”, added Matheny. “Mike’s hands on ...
(Date:5/21/2013)... WEST PALM BEACH, Fla. , May 21, ... Inc. (NYSE: FCN ), the global ... and enhance their enterprise value (the "Company"), announced ... sciences focused personnel that were formerly included within ... Forensic and Litigation Consulting segment to form a ...
Breaking Biology Technology:Oligomerix, Inc. Completes Series B Financing 2Oligomerix, Inc. Completes Series B Financing 3Cleveland BioLabs to Present at Second Annual Marcum LLP Microcap Conference 2Envera Appoints Michael McErlean Fermentation Manager 2FTI Consulting Releases Realigned Segment Information Reflecting Newly Combined Health Solutions Practice 2
... 4 Trubion Pharmaceuticals Inc.,(Nasdaq: TRBN ) ... vice president of research and development, is scheduled ... Biotechnology & Medical Technology,Conference on June 12 at ... at the,New York Palace Hotel in New York ...
... $90.7 million, up 18% from the prior year,s second ... quarter, - Earnings per share of $0.28, an increase of approximately 87% over last ... quarter,- Operating cash flow of $23.6 million (Year-to-date operating cash flow of ... $38.8 million),- Launch of eight new food and beverage and four new nutritional supplement ...
... Collegiate Inventors and Innovators Alliance (NCIIA) presents, ... discoveries for, nerve injuries, premature babies ... Mass., June 4 Today the NCIIA presented ... work in the field. The top winners in ...
Cached Biology Technology:Trubion Pharmaceuticals to Present at the 7th Annual Needham & Company Biotechnology & Medical Technology Conference 2Martek Announces Second Quarter 2008 Financial Results 2Martek Announces Second Quarter 2008 Financial Results 3Martek Announces Second Quarter 2008 Financial Results 4Martek Announces Second Quarter 2008 Financial Results 5Martek Announces Second Quarter 2008 Financial Results 6Martek Announces Second Quarter 2008 Financial Results 7Martek Announces Second Quarter 2008 Financial Results 8Martek Announces Second Quarter 2008 Financial Results 9Martek Announces Second Quarter 2008 Financial Results 10Martek Announces Second Quarter 2008 Financial Results 11Martek Announces Second Quarter 2008 Financial Results 12The NCIIA Recognizes Collegiate Biomedical Engineering Innovations 2The NCIIA Recognizes Collegiate Biomedical Engineering Innovations 3
(Date:5/21/2013)... in pharmacies and health stores, phosphatidylserine is a ... soy. Proven to improve cognition and slow memory ... experiencing memory impairment. Now a team headed by ... Tel Aviv University,s Department of Human Molecular ... improves the functioning of genes involved in degenerative ...
(Date:5/21/2013)... The largest gathering of biomass experts , ... , When? 03-07 June 2013 ... scientific research, resource assessment, market and policy developments, manufacturing ... the world and benefiting from its 2013 edition from ... more than 60 countries, more than 240 plenary and ...
(Date:5/20/2013)... Minnesota Medical School researchers from the Masonic Cancer Center, ... Tumor Program, have developed a new mouse model of ... to discover new genes and gene pathways driving this ... week in the journal Nature Genetics . , ... lab of David Largaespada, Ph.D., professor in the Medical ...
Breaking Biology News(10 mins):Common food supplement fights degenerative brain disorders 221st European Biomass Conference and Exhibition 221st European Biomass Conference and Exhibition 321st European Biomass Conference and Exhibition 4U of M researchers develop model for better testing, targeting of MPNST 2
... for the first time have shown the earliest stages ... of bones, teeth and sea shells. They ... a three-dimensional image of the nanoparticles that form the ... understanding of the formation of bones, teeth and shells. ...
... the most common vaginal infection in US women of childbearing ... the normal balance of bacteria in the vagina is disrupted ... BV puts a woman at increased risk for a variety ... in understanding how it can be prevented. Vitamin D may ...
... Va.The SNM Clinical Trials Network, an initiative designed ... through the integration of imaging biomarkers into multi-center ... supporter. SNM, the world,s largest medical and ... Clinical Trials Network in late 2008 to facilitate ...
Cached Biology News:Focus on the formation of bones, teeth and shells 2Vitamin D insufficiency linked to bacterial vaginosis in pregnant women 2SNM's clinical trials network gains added support from industry leader 2
Form: Ready to use Applications: ELISA...
... Strips have hydrophobic plastic supports that ... contact with toxic/hazardous solutions. Paper segments on ... leach into solution. Complementary indicator charts provide ... graduated in 1pH units; In packs of ...
... Analyzer for General Chemistries, Specialty Chemistries, QC, Reagent Development, Pharmaceutical Development, Physician Owned Labs, Drugs ... user-selectable wavelengths. ... ... ...
... System creates isogenic cell lines all ... the protein of interest. This homogeneous ... In this experiment the coding sequence ... into pcDNA5/FRT and transfected into Flp-In-293 ...
Biology Products: